State AG Pulse | The State AG: Both Advocate & Influencer
State AG Pulse | Swinging Through the Rust Belt, the Sun Belt and the South
From the Courtroom to the Capitol: Oregon AG Ellen Rosenblum Talks Leadership, Advocacy, and the Journey to Public Service – Regulatory Oversight Podcast
AGG Talks: Cross-Border Business - Navigating Inbound Franchising in the U.S.
A Conversation With NAAG Executive Director Brian Kane - Regulatory Oversight Podcast
A Conversation with NAAG President and Iowa Attorney General Tom Miller - Regulatory Oversight Podcast
CF on Cyber: Key Takeaways from the California AG’s Proposed CCPA Regulations
II-31- The Changing 9 to 5 From 1980 to Today
Carefully Crafted Allegations Still Control Early Resolutions
Enforcement under a Jeff Sessions DOJ
Polsinelli Podcasts - The Latest on a Shift in Regulation in Dietary Supplements
Bill on Bankruptcy: Sigmund Freud, Marx Brothers, Bernie Madoff
Bill on Bankruptcy: Secret Madoff Agreement May Harm Victims
Despite political and economic uncertainties, markets and deal activity were resilient in 2019, and strong fundamentals remain in place heading into 2020. Companies continue to face a challenging litigation and enforcement...more
House and Senate Return to Washington - Both the House and the Senate return to Washington next week. Throughout the week, the appropriations and authorizing committees will continue to hear from department and agency...more
Merle M. DeLancey Jr. While the introduction of state legislation that would require drug manufacturers to disclose pricing and other information did not slow down in 2018, the number of bills that were made law did slow...more
With opioid abuse continuing to dominate national headlines, manufacturers of opioid overdose medications are facing intense scrutiny over pricing practices that threaten (or those perceived as threatening) public...more
Vermont recently became the first state to require drug manufacturers to provide justification for price increases. Under the new law, data on the cost of the drug will come from the state Medicaid program. The Department of...more
Last week, Vermont adopted the first state law that requires drug companies registering the highest hike in prices to justify the rationale for the increase. Vermont policymakers are not alone pursuing laws that address...more
As a veteran of the AWP litigation era, I am struck by the recent state efforts to legislate transparency into pharmaceutical pricing. Multiple states have introduced bills that would require pharmaceutical manufacturers to...more